University of Mississippi Medical Center
His primary scientific interests are in Neuroscience, Prefrontal cortex, Major depressive disorder, Internal medicine and Endocrinology. His Neuroscience study frequently intersects with other fields, such as Glutamatergic. His work on Dorsolateral prefrontal cortex as part of general Prefrontal cortex study is frequently connected to Eukaryotic initiation factor, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His research in Major depressive disorder intersects with topics in mTORC1, Chronic stress and Molecular neuroscience. His Internal medicine research is multidisciplinary, incorporating perspectives in Anesthesia and Typical antipsychotic, Antipsychotic, Atypical antipsychotic. The concepts of his Endocrinology study are interwoven with issues in Clozapine, Serotonergic, Pharmacology and In vivo.
His main research concerns Internal medicine, Endocrinology, Neuroscience, Prefrontal cortex and Major depressive disorder. Internal medicine is closely attributed to Anesthesia in his work. His studies in Endocrinology integrate themes in fields like Receptor and Serotonin.
His research links Glutamate receptor with Neuroscience. The study incorporates disciplines such as GABAergic, Astrocyte and Pathology in addition to Prefrontal cortex. His Major depressive disorder research is multidisciplinary, incorporating elements of Dentate gyrus, Postmortem studies and Bioinformatics.
His primary areas of study are Internal medicine, Depression, Major depressive disorder, Endocrinology and Psychiatry. Craig A. Stockmeier combines subjects such as Bioinformatics, Prefrontal cortex, Axon, Messenger RNA and Genetic architecture with his study of Major depressive disorder. His Bioinformatics research includes elements of Dentate gyrus, Hippocampus, Hippocampal formation, Transcriptome and Neurogenesis.
His work carried out in the field of Prefrontal cortex brings together such families of science as Chromatin, Cause of death and Genetic association. His research integrates issues of Neuroscience, Dorsolateral prefrontal cortex, Neurotransmission and Serotonin in his study of Endocrinology. As part of his studies on Neuroscience, Craig A. Stockmeier frequently links adjacent subjects like Psychosis.
His primary areas of study are Major depressive disorder, Axon, Gene expression, Prefrontal cortex and Bioinformatics. His Major depressive disorder study introduces a deeper knowledge of Endocrinology. His Axon study is associated with Neuroscience.
His Gene expression research incorporates themes from Hippocampal formation, Neurogenesis and Hippocampus. His study looks at the relationship between Prefrontal cortex and topics such as Soma, which overlap with Pathology, Myelin and Messenger RNA. Craig A. Stockmeier has researched Bioinformatics in several fields, including Dentate gyrus, Meta-analysis, Depression and Genetic architecture.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression
Grazyna Rajkowska;José J Miguel-Hidalgo;Jinrong Wei;Ginny Dilley.
Biological Psychiatry (1999)
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression
Naomi R. Wray;Stephan Ripke;Stephan Ripke;Stephan Ripke;Manuel Mattheisen;MacIej Trzaskowski.
Nature Genetics (2018)
Cellular changes in the postmortem hippocampus in major depression.
Craig A. Stockmeier;Craig A. Stockmeier;Gouri J. Mahajan;Lisa C. Konick;James C. Overholser.
Biological Psychiatry (2004)
Decreased expression of synapse-related genes and loss of synapses in major depressive disorder
Hyo Jung Kang;Bhavya Voleti;Tibor Hajszan;Tibor Hajszan;Grazyna Rajkowska.
Nature Medicine (2012)
Astrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue
Grazyna Rajkowska;Craig A Stockmeier.
Current Drug Targets (2013)
Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity.
Craig A. Stockmeier;Laura A. Shapiro;Ginny E. Dilley;Tamara N. Kolli.
The Journal of Neuroscience (1998)
Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression
Violetta Klimek;Craig Stockmeier;James Overholser;Herbert Y. Meltzer.
The Journal of Neuroscience (1997)
Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies.
David C. Perry;Martha I. Dávila-Garcı́a;Craig A. Stockmeier;Kenneth J. Kellar.
Journal of Pharmacology and Experimental Therapeutics (1999)
GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression.
Grazyna Rajkowska;Gillian O'Dwyer;Zsofia Teleki;Craig A Stockmeier;Craig A Stockmeier.
A negative regulator of MAP kinase causes depressive behavior
Vanja Duric;Mounira Banasr;Pawel Licznerski;Heath D Schmidt.
Nature Medicine (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: